Wetzel A C, Vlassis J, Caffesse R G, Hämmerle C H, Lang N P
University of Berne, Switzerland.
Clin Oral Implants Res. 1999 Apr;10(2):111-9. doi: 10.1034/j.1600-0501.1999.100205.x.
The purpose of this study was to examine the healing potential and re-osseointegration in peri-implant infection defects adjacent to various implant surfaces. In 7 female Beagle dogs, a total of 41 titanium oral implants (ITI, Straumann, Waldenburg; Switzerland) with a sink depth of 6 mm (diameter 2.8 mm) were placed transmucosally. Four different surface configurations (TPS: titanium plasma sprayed (10); SLA: sand blasted and acid-etched (13); M: machined and smooth (11); TPS furc.: titanium plasma sprayed with coronally placed perforation to mimic a furcation (7) were distributed among the animals and locations. Following a healing period of 3 months, silk ligatures were placed and oral cleaning procedures abolished for 4 months to induce a vertical bone loss of about 40%. Following mechanical and chemical cleansing (chlorhexidine and metronidazole) and disinfection, the lesions were either sham operated (11) or subjected to a GTR procedure using ePTFE (30). After 6 months of healing the animals were killed and the jaws histologically evaluated. Six membranes were lost TPS: (1); SLA: (2); M: (2); TPS furc: (1) and 3 membranes exposed TPS: (1); M: (2) and excluded from further evaluation. Owing to the loss of 1 implant and infection of the membranes in the TPS furc group, this implant configuration was discarded from further analysis. For TPS surfaces, bone fill was 2.6 mm (73% of the distance from the bottom of the defect to the shoulder of the implant) sites with (4 GTR) and 0.33 mm (14%) for sites without membrane (2 controls). Re-osseointegration was 0.5 mm (14%) in the test group and 0.3 mm (14%) in the control. For SLA surfaces bone fill was 2.3 mm (83%) for sites with (7 GTR) and 0.41 mm (15%) for sites without membranes (4 controls). Re-osseointegration was 0.6 mm (20%) and 0.3 mm (11%) respectively. Corresponding values for M surfaces were 2.2 mm (62%) with 4 GTR) and 0.82 mm (31%) without membranes. Re-osseointegration was 0.07 mm (2%) and 0.19 mm (7%) respectively. This study has documented that peri-implant infections defects may heal with bone fill provided that the infection is controlled through effective antibacterial therapy. However, true reosseointegration appears to be difficult to achieve.
本研究的目的是检查不同种植体表面周围种植体感染缺损的愈合潜力和再骨结合情况。在7只雌性比格犬中,经黏膜植入41颗钛制口腔种植体(ITI,士卓曼,瓦尔登堡;瑞士),种植体下沉深度为6 mm(直径2.8 mm)。四种不同的表面结构(TPS:钛等离子喷涂(10颗);SLA:喷砂和酸蚀(13颗);M:机械加工且表面光滑(11颗);TPS分叉:钛等离子喷涂并在冠部设置穿孔以模拟分叉(7颗))分布于动物和种植位置。经过3个月的愈合期后,放置丝线结扎并停止口腔清洁程序4个月,以诱导约40%的垂直骨吸收。在进行机械和化学清洁(洗必泰和甲硝唑)及消毒后,对病变部位要么进行假手术(11处),要么使用ePTFE进行引导组织再生(GTR)手术(30处)。愈合6个月后处死动物,并对颌骨进行组织学评估。丢失6片膜:TPS组(1片);SLA组(2片);M组(2片);TPS分叉组(1片),3片膜暴露:TPS组(1片);M组(2片),这些被排除在进一步评估之外。由于TPS分叉组有1颗种植体丢失且膜发生感染,该种植体结构被排除在进一步分析之外。对于TPS表面,有膜(4处GTR)部位的骨填充为2.6 mm(占缺损底部到种植体肩部距离的73%),无膜部位(2处对照)为0.33 mm(14%)。试验组的再骨结合为0.5 mm(14%),对照组为0.3 mm(14%)。对于SLA表面,有膜(7处GTR)部位的骨填充为2.3 mm(83%),无膜部位(4处对照)为0.41 mm(15%)。再骨结合分别为0.6 mm(20%)和0.3 mm(11%)。M表面的相应值为有4处GTR时2.2 mm(62%),无膜时0.82 mm(31%)。再骨结合分别为0.07 mm(2%)和0.19 mm(7%)。本研究证明,只要通过有效的抗菌治疗控制感染,种植体周围感染缺损可通过骨填充实现愈合。然而,真正的再骨结合似乎难以实现。